Radium-223 Treatment of Patients with Metastatic Castration Resistant Prostate Cancer: Biomarkers for Stratification and Response Evaluation

por van der Zande, Kim, Oyen, Wim J. G., Zwart, Wilbert, Bergman, Andries M.
Publicado 2021

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond

por Linder, Simon, van der Poel, Henk G, Bergman, Andries M, Zwart, Wilbert, Prekovic, Stefan
Publicado 2018

Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl)

por van Rossum, Huub H., van Winden, Lennart J., Bergman, Andries M., van der Poel, Henk G.
Publicado 2023

Comparison of docetaxel pharmacokinetics between castration-resistant and hormone-sensitive metastatic prostate cancer patients

por Vermunt, Marit A. C., van Nuland, Merel, van der Heijden, Lisa T., Rosing, Hilde, Beijnen, Jos. H., Bergman, Andries M.
Publicado 2022

Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model

por Passier, Margot, van Genderen, Maisa N.G., Zaalberg, Anniek, Kneppers, Jeroen, Bekers, Elise M., Bergman, Andries M., Zwart, Wilbert, Eduati, Federica
Publicado 2023

Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer

por Nevedomskaya, Ekaterina, Stelloo, Suzan, van der Poel, Henk G., de Jong, Jeroen, Wessels, Lodewyk F.A., Bergman, Andries M., Zwart, Wilbert
Publicado 2015

mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma

por Stelloo, Suzan, Sanders, Joyce, Nevedomskaya, Ekaterina, de Jong, Jeroen, Peters, Dennis, van Leenders, Geert J.L.H., Jenster, Guido, Bergman, Andries M., Zwart, Wilbert
Publicado 2016

A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer

por Palit, Sander A. L., van Dorp, Jeroen, Vis, Daniel, Lieftink, Cor, Linder, Simon, Beijersbergen, Roderick, Bergman, Andries M., Zwart, Wilbert, van der Heijden, Michiel S.
Publicado 2021

Androgen receptor profiling predicts prostate cancer outcome

por Stelloo, Suzan, Nevedomskaya, Ekaterina, van der Poel, Henk G, de Jong, Jeroen, van Leenders, Geert JLH, Jenster, Guido, Wessels, Lodewyk FA, Bergman, Andries M, Zwart, Wilbert
Publicado 2015

Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models

por Bergman, Andries M., Adema, Auke D., Balzarini, Jan, Bruheim, Skjalg, Fichtner, Iduna, Noordhuis, Paul, Fodstad, Øystein, Myhren, Finn, Sandvold, Marit L., Hendriks, Hans R., Peters, Godefridus J.
Publicado 2010

Optimized ChIP-seq method facilitates transcription factor profiling in human tumors

por Singh, Abhishek A, Schuurman, Karianne, Nevedomskaya, Ekaterina, Stelloo, Suzan, Linder, Simon, Droog, Marjolein, Kim, Yongsoo, Sanders, Joyce, van der Poel, Henk, Bergman, Andries M, Wessels, Lodewyk FA, Zwart, Wilbert
Publicado 2018

Radiogenomics Analysis Linking Multiparametric MRI and Transcriptomics in Prostate Cancer

por Dinis Fernandes, Catarina, Schaap, Annekoos, Kant, Joan, van Houdt, Petra, Wijkstra, Hessel, Bekers, Elise, Linder, Simon, Bergman, Andries M., van der Heide, Uulke, Mischi, Massimo, Zwart, Wilbert, Eduati, Federica, Turco, Simona
Publicado 2023

The adaptive immune system promotes initiation of prostate carcinogenesis in a human c-Myc transgenic mouse model

por Melis, Monique H.M., Nevedomskaya, Ekaterina, van Burgsteden, Johan, Cioni, Bianca, van Zeeburg, Hester J.T., Song, Ji-Ying, Zevenhoven, John, Hawinkels, Lukas J.A.C, de Visser, Karin E., Bergman, Andries M.
Publicado 2017

Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases

por Severson, Tesa M., Zhu, Yanyun, De Marzo, Angelo M., Jones, Tracy, Simons, Jonathan W., Nelson, William G., Yegnasubramanian, Srinivasan, Freedman, Matthew L., Wessels, Lodewyk, Bergman, Andries M., Haffner, Michael C., Zwart, Wilbert
Publicado 2021

HLA class II expression on tumor cells and low numbers of tumor‐associated macrophages predict clinical outcome in oropharyngeal cancer

por Cioni, Bianca, Jordanova, Ekaterina S., Hooijberg, Erik, van der Linden, Rianne, de Menezes, Renee X., Tan, Katherine, Willems, Stefan, Elbers, Joris B. W., Broeks, Annegien, Bergman, Andries M., Zuur, Charlotte L., de Boer, Jan Paul
Publicado 2018

The Prognostic Potential of Human Prostate Cancer-Associated Macrophage Subtypes as Revealed by Single-Cell Transcriptomics

por Siefert, Joseph C., Cioni, Bianca, Muraro, Mauro J., Alshalalfa, Mohammed, Vivié, Judith, van der Poel, Henk G., Schoots, Ivo G., Bekers, Elise, Feng, Felix Y., Wessels, Lodewyk F.A., Zwart, Wilbert, Bergman, Andries M.
Publicado 2021

TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth

por Palit, Sander AL, Vis, Daniel, Stelloo, Suzan, Lieftink, Cor, Prekovic, Stefan, Bekers, Elise, Hofland, Ingrid, Šuštić, Tonći, Wolters, Liesanne, Beijersbergen, Roderick, Bergman, Andries M, Győrffy, Balázs, Wessels, Lodewyk FA, Zwart, Wilbert, van der Heijden, Michiel S
Publicado 2019

ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study

por Vermunt, Marit A. C., Robbrecht, Debbie G. J., Devriese, Lot A., Janssen, Julie M., Thijssen, Bas, Keessen, Marianne, van Eijk, Maarten, Kessels, Rob, Eskens, Ferry A. L. M., Beijnen, Jos H., Mehra, Niven, Bergman, Andries M.
Publicado 2021

Loss of androgen receptor signaling in prostate cancer‐associated fibroblasts (CAFs) promotes CCL2‐ and CXCL8‐mediated cancer cell migration

por Cioni, Bianca, Nevedomskaya, Ekaterina, Melis, Monique H. M., van Burgsteden, Johan, Stelloo, Suzan, Hodel, Emma, Spinozzi, Daniele, de Jong, Jeroen, van der Poel, Henk, de Boer, Jan Paul, Wessels, Lodewyk F. A., Zwart, Wilbert, Bergman, Andries M.
Publicado 2018

Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment Options

por Zuur, Lotte G., de Barros, Hilda A., van der Mijn, Koen J. C., Vis, André N., Bergman, Andries M., Pos, Floris J., van Moorselaar, Jeroen A., van der Poel, Henk G., Vogel, Wouter V., van Leeuwen, Pim J.
Publicado 2023